DK0505180T3 - Farmaceutisk præparat med højt indhold af ibuprofenlysinat - Google Patents

Farmaceutisk præparat med højt indhold af ibuprofenlysinat

Info

Publication number
DK0505180T3
DK0505180T3 DK92302372.5T DK92302372T DK0505180T3 DK 0505180 T3 DK0505180 T3 DK 0505180T3 DK 92302372 T DK92302372 T DK 92302372T DK 0505180 T3 DK0505180 T3 DK 0505180T3
Authority
DK
Denmark
Prior art keywords
ibuprofen lysinate
pharmaceutical preparation
high content
lysinate
ibuprofen
Prior art date
Application number
DK92302372.5T
Other languages
Danish (da)
English (en)
Inventor
Ashok V Katdare
Chungy Lui
Scott N Kleinbart
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK0505180T3 publication Critical patent/DK0505180T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DK92302372.5T 1991-03-22 1992-03-19 Farmaceutisk præparat med højt indhold af ibuprofenlysinat DK0505180T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67361391A 1991-03-22 1991-03-22

Publications (1)

Publication Number Publication Date
DK0505180T3 true DK0505180T3 (da) 1997-03-24

Family

ID=24703387

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92302372.5T DK0505180T3 (da) 1991-03-22 1992-03-19 Farmaceutisk præparat med højt indhold af ibuprofenlysinat

Country Status (10)

Country Link
US (1) US5622990A (fr)
EP (1) EP0505180B1 (fr)
JP (1) JPH0774154B2 (fr)
AT (1) ATE143805T1 (fr)
CA (1) CA2063689C (fr)
DE (1) DE69214333T2 (fr)
DK (1) DK0505180T3 (fr)
ES (1) ES2093192T3 (fr)
GR (1) GR3021320T3 (fr)
IE (1) IE75887B1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08504193A (ja) * 1992-12-02 1996-05-07 ザ ブーツ カンパニー ピーエルシー 方 法
IT1264855B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
DK0708771T3 (da) * 1993-07-15 1999-06-21 Pfizer Benzyloxyquinuclidiner som substans P antagonister
US6342530B1 (en) 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
US6344479B1 (en) 2001-03-20 2002-02-05 Farmacon-Il, Llc Method of preventing retinopathy of prematurity in a neonate
US6551615B1 (en) 2001-10-18 2003-04-22 M/S. Strides Arcolab Limited Dexibuprofen-containing soft gelatin capsules and process for preparing the same
EP1983983A4 (fr) * 2006-02-06 2009-11-25 Pharmaceutical Solutions Inc Poudre orale anti-inflammatoire non steroide et preparations liquides a administrer a des animaux
CN101544572B (zh) * 2008-03-26 2013-03-20 连云港恒邦医药科技有限公司 一种氨溴索衍生物及其制备方法
WO2011080502A2 (fr) 2009-12-29 2011-07-07 Orexo Ab Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique
US20120294937A1 (en) 2009-12-29 2012-11-22 Novartis Ag New pharmaceutical dosage form for the treatment of gastric acid-related disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1497044A (en) * 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
ZA855250B (en) * 1984-08-17 1986-02-26 Upjohn Co Stable,high dose,high bulk density ibuprofen granulations for tablet and capsule manufacturing
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US4994604A (en) * 1990-01-10 1991-02-19 Merck & Co., Inc. Formation and resolution of ibuprofen lysinate
US5087454A (en) * 1990-07-30 1992-02-11 American Home Products Corporation Ibuprofen tablet

Also Published As

Publication number Publication date
CA2063689C (fr) 1999-05-04
GR3021320T3 (en) 1997-01-31
ES2093192T3 (es) 1996-12-16
IE75887B1 (en) 1997-09-24
JPH0597667A (ja) 1993-04-20
JPH0774154B2 (ja) 1995-08-09
EP0505180B1 (fr) 1996-10-09
CA2063689A1 (fr) 1992-09-23
DE69214333D1 (de) 1996-11-14
EP0505180A1 (fr) 1992-09-23
IE920913A1 (en) 1992-09-23
ATE143805T1 (de) 1996-10-15
US5622990A (en) 1997-04-22
DE69214333T2 (de) 1997-04-24

Similar Documents

Publication Publication Date Title
IE862554L (en) Pharmaceutical compositions
SE8700498L (sv) Nya farmakologiskt aktiva foreningar
DK0585252T3 (da) Farmaceutiske formuleringer
IT1150608B (it) Complessi platino-diamminici e procedimento per la loro preparazione nonche' formulazioni farmaceutiche antitumorali contenenti tali complessi
DK0505180T3 (da) Farmaceutisk præparat med højt indhold af ibuprofenlysinat
ITTO920303A0 (it) "composizione farmaceutica antiinfiammatoria"
ES2039267T3 (es) Dihidropiridinamidas, procedimiento para su preparacion y su empleo en medicamentos.
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
TR27833A (tr) Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
FI923751A0 (fi) Hexahydrobenso/f/kinolinoner.
ITMI913510A0 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
NO951933L (no) Farmasöytiske formuleringer av ibuprofen
DE59004292D1 (de) Renin-hemmende Aminooligohydroxy-Derivate.
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
ATE145333T1 (de) Hirudin enthaltende orale arzneimittel
ATE90942T1 (de) (3-diethylaminopropyl)-1-amino-5methyldipyrido(4,3-b>(3,4-f>indoltrihydrochlori .
DE69111530T2 (de) Pyridincarbonsäure-Amid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
IT8719221A0 (it) Composizioni farmaceutiche contenenti levodopa metil estere, loro prodecimento di preparazione e relative applicazioni terapeutiche.
IT8620737A0 (it) Composizioni farmaceutiche contenenti levodopa metil estere, loro procedimento di preparazione e relative applicazioni terapeutiche.
ITMI912766A0 (it) Composizione farmaceutica contenente n-acetil-cisteina
ATE50995T1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
ITMI913461A0 (it) Composizioni terapeutiche adatte per la somministrazione rettale contenenti come principio attivo uno o piu' tioesteri del glutatione